Kenneth Nyblom is an experienced executive in the pharmaceutical sector, currently serving as the Managing Director and CEO of FGL: The Association for Generic Pharmaceuticals and Biosimilars in Sweden since April 2002. In addition, Kenneth holds positions as Chairman of the Board for Läkemedelsförsäkringen – Swedish National Pharmaceutical Insurance and e-VIS Swedish Medicines Verification Organisation, where leadership roles were assumed in June 2009 and March 2023, respectively. Kenneth is also the owner of KenMed AB, a consultancy established in May 2004. Previous roles include CEO/Managing Director at Alpharma and various managerial positions at Pharmacia & Upjohn. Kenneth earned a Master of Science degree in Business Studies and Economics from Uppsala University between 1989 and 1993.
Sign up to view 0 direct reports
Get started